Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study
- PMID: 37086006
- DOI: 10.1111/codi.16581
Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study
Abstract
Aim: Patients with Crohn's disease (CD) often suffer from perianal fistulizing disease. Their risk of anorectal cancer remains uncertain. We aimed to examine the long-term risk of anorectal cancer in a population-based cohort of CD patients with anorectal fistula.
Method: Our study population covered all individuals (n = 7 987 520) aged 15+ years living in Denmark from 1978 to 2018. We identified all patients with CD and anorectal fistula in the Danish National Patient Register (NPR) and 50 matched noninflammatory bowel disease (IBD) individuals from the general population. Using Cox regression analyses, we examined the risk of anorectal cancer in CD fistula patients versus non-IBD individuals. All patients with CD were identified using codes from the International Classification of Diseases and their data extracted from the NPR. The main outcome measure was cases of anorectal cancer.
Results: A total of 2786 CD patients with anorectal fistula and 139 300 non-IBD individuals were followed for 1 553 917 person-years. During follow-up, anorectal cancer was observed in 19 CD patients (0.68%) and 340 non-IBD individuals (0.24%), corresponding to a 2.9-fold increased hazard ratio (HR) of anorectal cancer in CD fistula patients (95% CI 1.80-4.53), with a particularly high risk of anal cancer (HR 15.13, 95% CI 6.88-33.31) and a mean time from CD fistula diagnosis to anorectal cancer of 6.7 (SD 6.5) years. The risk was slightly higher in women than men and had no apparent relation to treatment with tumour necrosis factor-α inhibitors. Sensitivity analyses using CD nonfistula patients for comparison revealed similar results. Individual data on smoking and infection with human papilloma virus were not available.
Conclusion: Patients with CD and anorectal fistula have a three-fold increased risk of anorectal cancer compared with the general population. The number needed to surveil to detect one case of anorectal cancer in this patient population was 2160 patients per year in patients with long-standing fistula (>6 years).
Keywords: Crohn's disease; anal fistula; anorectal cancer.
© 2023 Association of Coloproctology of Great Britain and Ireland.
Similar articles
-
High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn's Disease.Clin Gastroenterol Hepatol. 2018 Jun;16(6):892-899.e2. doi: 10.1016/j.cgh.2017.11.041. Epub 2017 Dec 2. Clin Gastroenterol Hepatol. 2018. PMID: 29199142
-
Fistula-Associated Anorectal Cancer in the Setting of Crohn's Disease.Dis Colon Rectum. 2016 Dec;59(12):1168-1173. doi: 10.1097/DCR.0000000000000700. Dis Colon Rectum. 2016. PMID: 27824702
-
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN Cohort.Clin Gastroenterol Hepatol. 2022 Mar;20(3):e484-e495. doi: 10.1016/j.cgh.2021.04.007. Epub 2021 Apr 9. Clin Gastroenterol Hepatol. 2022. PMID: 33845216
-
Perianal Crohn's Disease and the Development of Colorectal and Anal Cancer: A Systematic Review and Meta-analysis.J Crohns Colitis. 2023 Apr 3;17(3):361-368. doi: 10.1093/ecco-jcc/jjac143. J Crohns Colitis. 2023. PMID: 36130090
-
Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.Tech Coloproctol. 2017 Sep;21(9):683-691. doi: 10.1007/s10151-017-1684-y. Epub 2017 Sep 19. Tech Coloproctol. 2017. PMID: 28929282 Review.
References
REFERENCES
-
- Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769-78. https://doi.org/10.1016/S0140-6736(17)32448-0
-
- Papaconstantinou I, Mantzos DS, Kondi-Pafiti A, Koutroubakis IE. Anal adenocarcinoma complicating chronic Crohn's disease. Int J Surg Case Rep. 2015;10:201-3.
-
- Shwaartz C, Munger JA, Deliz JR, Bornstein JE, Gorfine SR, Chessin DB, et al. Fistula-associated anorectal cancer in the setting of Crohn's disease. Dis Colon Rectum. 2016;59:1168-73.
-
- Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TIA. Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol. 2005;100:2724-9.
-
- Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006;130:1039-46.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical